SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

25 Jul 2017 07:00

RNS Number : 9436L
Victrex PLC
25 July 2017
 
 

 

 

25 July 2017

 

Victrex plc: Interim Management Statement

 'Continued growth; well-placed for FY17'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its Interim Management Statement for the third quarter (Q3) covering the period 1 April to 30 June 2017.

The Group has performed well since the end of the first half and cash generation has continued to be strong.

 

Although the second half sees a tougher volume comparative, particularly for Q4, our core business has remained in good growth, with Automotive, Electronics (ex-Consumer) and Value Added Resellers being notably strong. As expected, whilst we saw some Consumer Electronics volumes during Q3, these were lower than the prior year.

 

In Medical, the mature US Spine market continues to be a challenge to short term-growth although Q3 performance was slightly ahead of the prior year in constant currency. Pleasingly, our differentiated and innovative PEEK-OPTIMATM HA Enhanced product, a premium and next generation offering which promotes bone-on growth, has now secured first meaningful revenues of over £1m and adoption rates are progressing.

 

Overall, Q3 Group revenue* was up 26% to £76.3m (Q3 2016: £60.6m), with Group sales volume up 6% to 1,022 tonnes (Q3 2016: 966 tonnes). Year to date Group sales volume of 2,881 tonnes is 5% up on the prior year (2016 YTD: 2,736 tonnes), with year to date Group revenue of £207.3m up 17% (2016 YTD: £177.6m).

Currency continues to support top-line revenues, with hedges placed at more favourable currency rates benefiting us during the second half year. The anticipated currency benefit for our 2017 financial year is unchanged, and is expected to be weighted approximately one-third/two-thirds between the first and second half. For 2018, we are now over 60% covered for our currency hedging programme.

 

In our growth pipeline, as well as meaningful revenue for PEEK-OPTIMATM HA Enhanced, several 2017 milestones have now been delivered. In Automotive, in addition to our agreement to supply PEEK Gears to a major European Automotive manufacturer from 2018, we now have several new market-wide development programmes with global manufacturers. In Aerospace, construction of our US manufacturing facility is progressing for our TxV Aero Composites joint venture, following pre-qualification of our differentiated grades for loaded brackets last year. We are also developing some strategic alliances in the Aerospace supply chain, as part of our focus on composite parts, to complement this joint-venture.

 

Outlook

For the remainder of 2017, Consumer Electronics volumes are now expected to be lower than our previous guidance, although market-wide engagement programmes are progressing, offering both volume and value opportunities for 2018, including for differentiated applications. Overall, our strong core business performance is more than offsetting lower Consumer Electronics and may now offer a degree of upside potential for the full year. Victrex remains well placed for 2017 and we continue to be comfortable with current expectations.

 

For the medium to longer term, Victrex remains in a good position, with a Polymer & Parts strategy to increase our differentiation, a strong pipeline of potentially game-changing projects, a focus on cost efficiency and a highly cash generative business model.

 

 

Notes:

 

*Q3 and YTD revenue for FY 2017 includes sales from the Zyex PEEK fibres acquisition (completed in April 2017).

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

 

Teneo Blue Rubicon:

Charles Armitstead +44 (0) 207 260 2700

 

 

Analyst & investor conference call

A conference call for analysts & investors will be held today at 08.30 BST. Dial in details: +44 (0) 203 139 4830, pin 54398114#

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy (including manufacturing & engineering), electronics and medical. Every day, millions of people use products and applications, which contain our materials - from smart phones, aeroplanes and cars to oil and gas operations and medical devices. With over 35 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUWPMUPMGQC
Date   Source Headline
8th Feb 20117:00 amRNSAGM and Interim Management Statement
31st Jan 20114:36 pmRNSTotal Voting Rights
19th Jan 20112:33 pmRNSDirector/PDMR Shareholding
13th Jan 201111:59 amRNSHolding(s) in Company
10th Jan 20117:00 amRNSBoard Change
4th Jan 20113:30 pmRNSAnnual Information Update
4th Jan 20113:21 pmRNSTotal Voting Rights
22nd Dec 201012:43 pmRNSAnnual Financial Report
14th Dec 20103:09 pmRNSDirector/PDMR Shareholding
10th Dec 201012:04 pmRNSDirector/PDMR Shareholding
9th Dec 20109:27 amRNSHolding(s) in Company
8th Dec 20104:16 pmRNSDirector/PDMR Shareholding
8th Dec 201010:00 amRNSHolding(s) in Company
7th Dec 20107:00 amRNSFinal Results
1st Dec 201010:58 amRNSBlocklisting Interim Review
30th Nov 20102:54 pmRNSTotal Voting Rights
17th Nov 20104:07 pmRNSDirector/PDMR Shareholding
16th Nov 20103:38 pmRNSDirector Declaration
1st Nov 20102:11 pmRNSTotal Voting Rights
20th Oct 20102:11 pmRNSDirector/PDMR Shareholding
20th Oct 20102:11 pmRNSDirector/PDMR Shareholding
7th Oct 20107:00 amRNSAnnual Trading Update
1st Oct 20102:01 pmRNSTotal Voting Rights
17th Sep 20101:24 pmRNSDirector/PDMR Shareholding
15th Sep 201012:13 pmRNSHolding(s) in Company
31st Aug 201012:16 pmRNSTotal Voting Rights
17th Aug 20101:05 pmRNSDirector/PDMR Shareholding
5th Aug 20107:00 amRNSInterim Management Statement
5th Aug 20107:00 amRNSBoard Change
3rd Aug 201010:47 amRNSDirector Declaration
28th Jul 201012:53 pmRNSHolding(s) in Company
19th Jul 20102:48 pmRNSDirector/PDMR Shareholding
2nd Jul 20101:06 pmRNSDirector Declaration
30th Jun 20102:46 pmRNSTotal Voting Rights
22nd Jun 201011:06 amRNSDirector/PDMR Shareholding
18th Jun 201012:07 pmRNSDirector/PDMR Shareholding
7th Jun 20101:48 pmRNSDirector/PDMR Shareholding
2nd Jun 20102:37 pmRNSDirector/PDMR Shareholding
2nd Jun 201010:15 amRNSBlocklisting Interim Review
1st Jun 20103:49 pmRNSTotal Voting Rights
1st Jun 20103:34 pmRNSDirector/PDMR Shareholding
25th May 20107:00 amRNSHalf Yearly Report
18th May 20104:28 pmRNSDirector/PDMR Shareholding
30th Apr 201011:58 amRNSTotal Voting Rights
23rd Apr 201010:53 amRNSDirector Declaration
19th Apr 20102:52 pmRNSDirector/PDMR Shareholding
19th Apr 201011:41 amRNSHolding(s) in Company
12th Apr 20103:52 pmRNSHolding(s) in Company
9th Apr 20101:43 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.